Skip to search boxSkip to navigationSkip to main content

Rapid initiation of nasal saline irrigation to reduce severity in high-risk COVID+ outpatients

*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Abstract

Objective: To determine whether initiating saline nasal irrigation after COVID-19 diagnosis reduces hospitalization and death in high-risk outpatients compared with observational controls, and if irrigant composition impacts severity. Methods: Participants 55 and older were enrolled within 24 hours of a + PCR COVID-19 test between September 24 and December 21, 2020. Among 826 screened, 79 participants were enrolled and randomly assigned to add 2.5 mL povidone-iodine 10% or 2.5 mL sodium bicarbonate to 240 mL of isotonic nasal irrigation twice daily for 14 days. The primary outcome was hospitalization or death from COVID-19 within 28 days of enrollment by daily self-report confirmed with phone calls and hospital records, compared to the CDC Surveillance Dataset covering the same time. Secondary outcomes compared symptom resolution by irrigant additive. Results: Seventy-nine high-risk participants were enrolled (mean [SD] age, 64 [8] years; 36 [46%] women; 71% Non-Hispanic White), with mean BMI 30.3. Analyzed by intention-to-treat, by day 28, COVID-19 symptoms resulted in one ED visit and no hospitalizations in 42 irrigating with alkalinization, one hospitalization of 37 in the povidone-iodine group, (1.27%) and no deaths. Of nearly three million CDC cases, 9.47% were known to be hospitalized, with an additional 1.5% mortality in those without hospitalization data. Age, sex, and percentage with pre-existing conditions did not significantly differ by exact binomial test from the CDC dataset, while reported race and hospitalization rate did. The total risk of hospitalization or death (11%) was 8.57 times that of enrolled nasal irrigation participants (SE = 2.74; P =.006). Sixty-two participants completed daily surveys (78%), averaging 1.8 irrigations/day. Eleven reported irrigation-related complaints and four discontinued use. Symptom resolution was more likely for those reporting twice daily irrigation (X2 = 8.728, P =.0031) regardless of additive. Conclusion: SARS-CoV-2+ participants initiating nasal irrigation were over 8 times less likely to be hospitalized than the national rate.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 30S-39S

Journal (Volume, Issue Number)

Ear, Nose and Throat Journal (Volume 103, Issue 1_suppl)

Publication milestones

  • Accepted/In press - 2022
  • Published - 06/2024

Publication status

Published - 06/2024

ISSN

0145-5613

Publication IDs

  • Scopus: 85137252361
  • PubMed: 36007135
  • ORCID: /0000-0002-1075-4303/work/161521578

Publication metrics

Metrics

Fractional count
5
Fractional count
0.42
Fractional count
7
Fractional count
0.58
Fractional count
5
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Captures
50
Mentions
89
Citation count
21

Funding Details

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the unrestricted research funds from the Bernard and Anne Gray Donor Advised Fund Community Foundation for Greater Atlanta, Neilmed Inc., and Rhinosystems.
FundersFunding numbers
Bernard and Anne Gray Donor Advised Fund Community Foundation for Greater Atlanta
-
Neilmed Inc.
-